$HHS

HARTE HANKS INC

No enriched coverage for $HHS in the last 7 days.

No SEC Form 4 filings for $HHS in the last 30 days.

Low

Harte Hanks, Inc. Q1 2026 Financial Report: Revenue, Segment Performance, and Accounting Policies Overview

Harte Hanks, Inc. (NASDAQ: HHS) has released its Q1 2026 financial results, reporting a narrowed net loss of $392,000 compared to Q1 2025, though EPS showed a deeper loss. The Revenue Solutions segment generated $7.92 million, highlighting its importance as the primary revenue driver, while the company maintains a healthy liquidity position with $8.98 million in cash. Investors are advised to monitor the company's path to profitability and segment performance due to ongoing losses and slight equity erosion.

Harte Hanks ( HHS ) Q2 Revenue Falls 14%

Harte Hanks ( NASDAQ:HHS ) , a marketing and customer experience solutions provider, released its results on August 7, 2025. The most important news from the release was a broad drop in GAAP revenues and profitability, with revenue ( GAAP ) and EBITDA declining sharply across all business ...

News on $HHS